Search research articles
Contact Us
Filters
Showing results (141-150 of 149) with videos related to
Page
of 15
Sort By:
You have reached the last page of results.
This site can display upto 149 results.
Journal of Medicinal Chemistry
|
January 10, 2015
Discovery of an oral respiratory syncytial virus (RSV) fusion inhibitor (GS-5806) and clinical proof of concept in a human RSV challenge study
Richard L Mackman, Michael Sangi, David Sperandio, et al.
NPJ Vaccines
|
September 29, 2025
Synergistic effect of nucleoside modification and ionizable lipid composition on translation and immune responses to mRNA vaccines
Hillary Danz, Allison Dauner, Shraddha Sharma, et al.
Science Translational Medicine
|
June 30, 2017
Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses
Timothy P Sheahan, Amy C Sims, Rachel L Graham, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 19, 2008
Severe eczema vaccinatum in a household contact of a smallpox vaccinee
Surabhi Vora, Inger Damon, Vincent Fulginiti, et al.
Journal of Medicinal Chemistry
|
April 9, 2021
Prodrugs of a 1'-CN-4-Aza-7,9-dideazaadenosine <i>C</i>-Nucleoside Leading to the Discovery of Remdesivir (GS-5734) as a Potent Inhibitor of Respiratory Syncytial Virus with Efficacy in the African Green Monkey Model of RSV
Richard L Mackman, Hon C Hui, Michel Perron, et al.
Journal of Medicinal Chemistry
|
January 27, 2017
Discovery and Synthesis of a Phosphoramidate Prodrug of a Pyrrolo[2,1-f][triazin-4-amino] Adenine C-Nucleoside (GS-5734) for the Treatment of Ebola and Emerging Viruses
Dustin Siegel, Hon C Hui, Edward Doerffler, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 4, 2019
A Phase 2, Randomized, Double-blind, Placebo-Controlled Trial of Presatovir for the Treatment of Respiratory Syncytial Virus Upper Respiratory Tract Infection in Hematopoietic-Cell Transplant Recipients
Roy F Chemaly, Sanjeet S Dadwal, Anne Bergeron, et al.
The Journal of Infectious Diseases
|
September 5, 2023
Report of the Assay Guidance Workshop on 3-Dimensional Tissue Models for Antiviral Drug Development
Robert Jordan, Stephanie L Ford-Scheimer, Rodolfo M Alarcon, et al.
Nature
|
March 3, 2016
Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys
Travis K Warren, Robert Jordan, Michael K Lo, et al.
Page
of 15
Search research articles
Search
Showing results (141-150 of 149) with videos related to
Sort By:
Page
of 15
You have reached the last page of results.
This site can display upto 149 results.
Journal of Medicinal Chemistry
|
January 10, 2015
Discovery of an oral respiratory syncytial virus (RSV) fusion inhibitor (GS-5806) and clinical proof of concept in a human RSV challenge study
Richard L Mackman, Michael Sangi, David Sperandio, et al.
NPJ Vaccines
|
September 29, 2025
Synergistic effect of nucleoside modification and ionizable lipid composition on translation and immune responses to mRNA vaccines
Hillary Danz, Allison Dauner, Shraddha Sharma, et al.
Science Translational Medicine
|
June 30, 2017
Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses
Timothy P Sheahan, Amy C Sims, Rachel L Graham, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 19, 2008
Severe eczema vaccinatum in a household contact of a smallpox vaccinee
Surabhi Vora, Inger Damon, Vincent Fulginiti, et al.
Journal of Medicinal Chemistry
|
April 9, 2021
Prodrugs of a 1'-CN-4-Aza-7,9-dideazaadenosine <i>C</i>-Nucleoside Leading to the Discovery of Remdesivir (GS-5734) as a Potent Inhibitor of Respiratory Syncytial Virus with Efficacy in the African Green Monkey Model of RSV
Richard L Mackman, Hon C Hui, Michel Perron, et al.
Journal of Medicinal Chemistry
|
January 27, 2017
Discovery and Synthesis of a Phosphoramidate Prodrug of a Pyrrolo[2,1-f][triazin-4-amino] Adenine C-Nucleoside (GS-5734) for the Treatment of Ebola and Emerging Viruses
Dustin Siegel, Hon C Hui, Edward Doerffler, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 4, 2019
A Phase 2, Randomized, Double-blind, Placebo-Controlled Trial of Presatovir for the Treatment of Respiratory Syncytial Virus Upper Respiratory Tract Infection in Hematopoietic-Cell Transplant Recipients
Roy F Chemaly, Sanjeet S Dadwal, Anne Bergeron, et al.
The Journal of Infectious Diseases
|
September 5, 2023
Report of the Assay Guidance Workshop on 3-Dimensional Tissue Models for Antiviral Drug Development
Robert Jordan, Stephanie L Ford-Scheimer, Rodolfo M Alarcon, et al.
Nature
|
March 3, 2016
Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys
Travis K Warren, Robert Jordan, Michael K Lo, et al.
Page
of 15